Table 3 Subgroup analysis over availability of drug category among hospitals with respiratory department (n = 547).

 < 50 (n = 111)

99 (89.19%)

16 (14.41%)

60 (54.05%)

70 (63.06%)

50 (45.05%)

90 (81.08%)

55 (49.55%)

102 (91.89%)

81 (72.97%)

102 (91.89%)

27 (24.32%)

 50–80 (n = 225)

208 (92.44%)

50 (22.22%)

146 (64.89%)

204 (90.67%)

162 (72.00%)

221 (98.22%)

175 (77.78%)

221 (98.22%)

177 (78.67%)

206 (91.56%)

75 (33.33%)

 80–120 (n = 128)

118 (92.19%)

44 (34.38%)

82 (64.06%)

117 (91.41%)

90 (70.31%)

123 (96.09%)

103 (80.47%)

123 (96.09%)

88 (68.75%)

118 (92.19%)

48 (37.50%)

 > 120 (n = 83)

81 (97.59%)

31 (37.35%)

67 (80.72%)

80 (96.39%)

69 (83.13%)

82 (98.80%)

68 (81.93%)

83 (100.00%)

57 (68.67%)

83 (100.00%)

40 (48.19%)

p

0.181

< 0.001

0.002

< 0.001

< 0.001

< 0.001

< 0.001

0.005

0.133

0.061

0.006

 ≤ 10 (n = 241)

219 (90.87%)

40 (16.60%)

143 (59.34%)

190 (78.84%)

139 (57.68%)

223 (92.53%)

160 (66.39%)

233 (96.68%)

186 (77.18%)

220 (91.29%)

70 (29.05%)

 11–20 (n = 174)

161 (92.53%)

50 (28.74%)

111 (63.79%)

158 (90.80%)

128 (73.56%)

164 (94.25%)

132 (75.86%)

166 (95.40%)

129 (74.14%)

162 (93.10%)

60 (34.48%)

 21–30 (n = 63)

59 (93.65%)

18 (28.57%)

48 (76.19%)

58 (92.06%)

51 (80.95%)

63 (100.00%)

54 (85.71%)

61 (96.83%)

44 (69.84%)

60 (95.24%)

27 (42.86%)

 > 30 (n = 69)

67 (97.10%)

33 (47.83%)

53 (76.81%)

65 (94.20%)

53 (76.81%)

66 (95.65%)

55 (79.71%)

69 (100.00%)

44 (63.77%)

67 (97.10%)

33 (47.83%)

p

0.369

< 0.001

0.011

< 0.001

< 0.001

0.140

0.005

0.350

0.138

0.337

0.015